Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 499-502

  Guo, Zhanjun ^a   Yang, Hua ^a   Wang, Cuiju ^b   Liu, Shufeng ^b  

^a Departments of Gastroenterology and Hepatology   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Age at onset; Displacement loop; Hepatocellular carcinoma; Single nucleotide polymorphism

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ALLELE; ARTICLE; CANCER RISK; FEMALE; GENETIC ASSOCIATION; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84862924331     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.434     Document Type: Article

References (36)

1. G oma a A I, K ha n SA, Toledano MB, Waked I and Taylor-Robinson SD: hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 14: 4300-4308, 2008.
2. Sun Z, Ming L, Zhu X and Lu J: Prevetion and control of hepatitis B in China. J Med Virol 67: 447-450, 2002.
3. Ferlay J, Bray F, Pisani P and Parkin DM (eds): Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. IARC Press, Lyon, 2001.
4. Caldwell S and Park SH: The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 44: 96-101, 2009.
5. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H and Rusyn I: Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Anal Surg Oncol 14: 1182-1190, 2007.
6. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M and Hirohashi S: Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106: 1618-1624, 1994.
7. Minagawa M, Makuuchi M, Takayama T and Kokudo N: Selection criteria for repeat hepatectomy in patients with recurrent hepato-cellular carcinoma. Ann Surg 238: 703-710, 2003.
8. Wong N, Yeo W, Wong WL, Wong NL, Chan KY, Mo FK, Koh J, Chan SL, Chan AT, Lai PB, et al: TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer 124: 644-652, 2009.
9. Schwarz KB: Oxidative stress during viral infection: a review. Free Radical Biol Med 21: 641-649, 1996.
10. Mansouri A, Fromenty B, Berson A, Robin MA, Grimbert S, Beaugrand M, Erlingr S and Pessayre D: Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol 27: 96-102, 1997.
11. Shadel GS and Clayton DA: Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 66: 409-435, 1997.
12. DiMauro S and Schon EA: Mitochondrial DNA mutations in human disease. Am J Med Genet 106: 18-26, 2001.
13. Beal MF: Mitochondia, free radicals, and neurodegeneration. Curr Opin Neurobiol 6: 661-666, 1996.
14. Lightowlers RN, Chinnery PF, Turnbull DM, and Howell N: Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13: 450-455, 1997.
15. Wallace DC: Mouse models for mitochondrial disease. Am J Med Genet 106: 71-93, 2001.
16. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J and Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000.
17. Nomoto S, Yamashita K, Koshikawa K, Nakao A and Sidransky D: Mitochondrial D-loop mutation as clonal markers in multicentric hepatocellular carcimona and plasma. Clin Cancer Res 8: 481-487, 2002.
18. Mambo E, Gao X, Cohen Y, Guo Z, Talalay P and Sidransky D: Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci USA 100: 1838-1843, 2003.
19. Yoneyama H, Hara T, Kato Y, Yamori T, Matsuura ET and Koike K: Nucleotide sequence variation is frequently in the mitochondrial DNA displacement loop region of individual human tumor cells. Mol Cancer Res 3: 14-20, 2005.
20. Jakupciak JP, Maragh S, Markowitz ME, Greenberg AK, Hoque MO, Maitra A, Barker PE, Wagner PD, Rom WN, Srivastava S, Sidransky D and O'Connell CD: Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer 8: 285, 2008.
21. Nashikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E and Inoue M: Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61: 1843-1845, 2001.
22. Sanchez-Cespedes Mrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM and Sidransky D: Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61: 7015-7019, 2001.
23. Taanman JW: The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123, 1999.
24. Zhang R, Zhang F, Wang C, Wang S, Shiao Y-H and Guo Z: Identification of sequence polymorphism in the D-loop region of mitochondria DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29: 130, 2010.
25. Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S and Guo Z: Sequence polymorphisms of mitochondrial D-loop and hepato- cellular carcinoma outcome. Biochem Biophys Res Commu 406: 493-496, 2011.
26. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi Senti A, Pedrazzoli S and Plebani M: Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol 126: 593-601, 2006.
27. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN and Petersen GM: Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16: 1455-1459, 2007.
28. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, Schaid DJ and Thibodeau SN: Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17: 3558-3566, 2008.
29. Zhang R, Wang R, Zhang F, Wu C, Fan H, li Y, Wang C and Guo Z: Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 29: 155, 2010.
30. González AM, Larruga JM, Abu-Amero KK, Shi Y, Pestano J and Cabrera VM: Mitochondrial lineage M1 traces an early human backflow to Africa. BMC Genomics 8: 223, 2007.
31. Carelli V, Achilli A, Valentino ML, Rengo C, Semino O, Pala M, Olivieri A, Mattiazzi M, Pallotti F, Carrara F, et al: Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet 78: 564-574, 2006.
32. Udar N, Atilano SR, Memarzadeh M, Boyer DS, Chwa M, Lu S, Maguen B, Langberg J, Coskun P, Wallace DC, et al: Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 1966-2974, 2009.
33. Bandy B and Davision AJ: Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 8: 523-539, 1990.
34. Gille JJ and Joenje H: Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric heperoxia. Mutat Res 275: 405-414, 1992.
35. Shigenaga MK, Hagen TM and Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771-10778, 1994.
36. Dement GA, Maloney SC and Reeves R: Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp Cell Res 313: 77-87, 2007.